|
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Sep. 30, 2011
|
Sep. 30, 2010
|
Sep. 30, 2009
|
| Operating Activities: |
|
|
|
| Net Income (Loss) |
$ (53,393) |
$ 136,860 |
$ (23,183) |
| Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by (Used in) Operating Activities: |
|
|
|
| Depreciation |
21,857 |
23,037 |
14,279 |
| Deferred Income Taxes |
(5,496) |
75,970 |
(16,032) |
| Reclassification from Accumulated Other Comprehensive Income (Loss) to Net Income (Loss) |
(8,855) |
1,506 |
7,448 |
| Cash (Paid) Received on Change in Fair Value of Derivative Instruments |
19,335 |
(1,922) |
(5,108) |
| Gain on Contribution of Assets to Joint Venture |
(3,598) |
|
|
| Equity (Earnings) Loss in Unconsolidated Investees |
499 |
(4,435) |
(2,481) |
| Impairment of Investments in Unconsolidated Investees |
7,123 |
|
|
| Income from Discontinued Operations |
|
|
(644) |
| Stock-Based Compensation Expense |
2,173 |
1,992 |
2,502 |
| Reduction of Fair Value of Guarantee |
(700) |
|
|
| Excess Tax Benefits from Stock-Based Compensation |
379 |
39 |
141 |
| Savannah Event Related Impairment Charges: |
|
|
|
| Inventory destroyed or damaged |
|
|
1,639 |
| Property Plant and Equipment |
|
|
405 |
| Insurance Recoveries Recognized |
|
(278,473) |
(30,404) |
| Advances from Insurance Carriers |
|
|
60,000 |
| Other |
408 |
254 |
(174) |
| Changes in Operating Assets and Liabilities: |
|
|
|
| Accounts Receivable |
949 |
(20,492) |
(6,137) |
| Income Tax Receivable |
|
|
12,704 |
| Inventories |
42,786 |
(1,100) |
(13,966) |
| Prepaid Expenses and Other Assets |
3,221 |
(2,710) |
(5,789) |
| Accounts Payable, Raw Sugar |
(58,212) |
38,888 |
12,767 |
| Accounts Payable, Other Trade |
(8,980) |
5,891 |
(2,423) |
| Other Liabilities |
(14,960) |
(7,242) |
(4,829) |
| Net Cash Provided by (Used in) Continuing Operations |
(55,464) |
(31,937) |
715 |
| Net Cash Provided by Discontinued Operations |
|
|
1,015 |
| Net Cash Provided by (Used in) Operating Activities |
(55,464) |
(31,937) |
1,730 |
| Investing Activities: |
|
|
|
| Capital Expenditures |
(24,803) |
(72,337) |
(160,762) |
| Advances from Insurance Carriers |
|
51,000 |
134,000 |
| Proceeds from Sale of Marketable Securities |
|
|
7,754 |
| Proceeds from Sales of Assets |
|
|
538 |
| Other |
(369) |
(266) |
(7) |
| Net Cash (Used in) Investing Activities |
(25,172) |
(21,603) |
(18,477) |
| Financing Activities: |
|
|
|
| Borrowing (Repayments) under Revolving Credit Line, Net |
59,843 |
(38,000) |
60,000 |
| Cash Dividends |
(1,054) |
(1,050) |
(2,319) |
| Stock Option and Warrant Proceeds |
|
|
79 |
| Excess Tax Benefits from Stock-Based Compensation |
(379) |
(39) |
(141) |
| Other |
(390) |
(205) |
(11) |
| Net Cash Provided by (Used in) Financing Activities |
58,020 |
(39,294) |
57,608 |
| Increase (Decrease) in Cash and Cash Equivalents |
(22,616) |
(92,834) |
40,861 |
| Cash and Cash Equivalents, Beginning of Period |
22,750 |
115,584 |
74,723 |
| Cash and Cash Equivalents, End of Period |
134 |
22,750 |
115,584 |
| Supplemental Non-Cash Items: |
|
|
|
| Tax Effect of Deferred Gains and Losses |
|
2,992 |
19,330 |
| Purchase of Property, Plant and Equipment on Account |
$ 1,008 |
$ 6,797 |
$ 28,718 |